HRS expert consensus statement on the diagnosis and management of arrhythmias associated with cardiac sarcoidosis. - Wikidata - wikimedia - TriplyDB

HRS expert consensus statement on the diagnosis and management of arrhythmias associated with cardiac sarcoidosis.

HRS expert consensus statement on the diagnosis and management of arrhythmias associated with cardiac sarcoidosis.

http://www.wikidata.org/entity/Q34419644

about

Pulmonary hypertension complicating pulmonary sarcoidosis Cardiac sarcoidosis-state of the art review Infiltrative Cardiomyopathies Management of Arrhythmias in Cardiac Sarcoidosis Role of cardiovascular magnetic resonance in the guidelines of the European Society of Cardiology.Atrial Fibrillation in Cardiac Sarcoidosis 2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: The Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the Presence of Late Gadolinium Enhancement by Cardiac Magnetic Resonance Among Patients With Suspected Cardiac Sarcoidosis Is Associated With Adverse Cardiovascular Prognosis: A Systematic Review and Meta-Analysis.Prognostic Value of Myocardial Scarring on CMR in Patients With Cardiac Sarcoidosis.Pathophysiology and clinical management of cardiac sarcoidosis.Benefit of magnetic resonance-conditional cardiac resynchronization therapy defibrillator: A case of cardiac sarcoidosis-involved cervical extradural lesion.Left ventricular aneurysm and ventricular tachycardia as initial presentation of cardiac sarcoidosis Cardiac sarcoidosis resembling panic disorder: a case report Prognosis of Myocardial Damage in Sarcoidosis Patients With Preserved Left Ventricular Ejection Fraction: Risk Stratification Using Cardiovascular Magnetic Resonance.Cardiac Sarcoidosis: Is it More Common in Men?The effects of 18-h fasting with low-carbohydrate diet preparation on suppressed physiological myocardial (18)F-fluorodeoxyglucose (FDG) uptake and possible minimal effects of unfractionated heparin use in patients with suspected cardiac involvement Insights into biopsy-proven cardiac sarcoidosis in patients with heart failure.Magnetic Resonance Imaging as a Predictor of Survival Free of Life-Threatening Arrhythmias and Transplantation in Cardiac Sarcoidosis.A dual tracer (68)Ga-DOTANOC PET/CT and (18)F-FDG PET/CT pilot study for detection of cardiac sarcoidosis.Prevalence of cardiac sarcoidosis in white population: a case-control study: Proposal for a novel risk index based on commonly available tests Development of Evidence-based Recommendations: Implications for Preparing Expert Consensus Statements.Myocardial Immunocompetent Cells and Macrophage Phenotypes as Histopathological Surrogates for Diagnosis of Cardiac Sarcoidosis in Japanese.Prevention of sudden cardiac death by the wearable cardioverter defibrillator in a young patient with cardiac sarcoidosis.Somatostatin receptor based PET/CT in patients with the suspicion of cardiac sarcoidosis: an initial comparison to cardiac MRI.The Clinical Features of Sarcoidosis: A Comprehensive Review.Outcomes of patients with definite and suspected isolated cardiac sarcoidosis treated with an implantable cardiac defibrillator.Current status of nuclear cardiology in Japan: Ongoing efforts to improve clinical standards and to establish evidence.Cardiac sarcoidosis: diagnosis and management.Advances in radionuclide imaging of cardiac sarcoidosis.Comparative evaluation of 18F-FLT and 18F-FDG for detecting cardiac and extra-cardiac thoracic involvement in patients with newly diagnosed sarcoidosis.Diagnosis and treatment of cardiac sarcoidosis.A Diagnostic and Therapeutic Approach to Arrhythmias in Cardiac Sarcoidosis.Risk assessment of patients with clinical manifestations of cardiac sarcoidosis with positron emission tomography and magnetic resonance imaging.Update on Treatment in Cardiac Sarcoidosis.Recent Advances in Nuclear Cardiology Deciphering cardiac involvement in systemic inflammatory diseases: noninvasive tissue characterisation using cardiac magnetic resonance is key to improved patients' care.Biomarkers in sarcoidosis.Cardiac manifestations of sarcoidosis: diagnosis and management.Medical therapy to prevent recurrence of ventricular arrhythmia in normal and structural heart disease patients.Heart Rhythm Society: expert consensus statements-part 1.

P2860

Q26748574-60E5F702-0DDF-457C-8CBD-E36DA126C232 Q26765213-209C8844-0AA7-496D-B162-6A11252FF89A Q26798533-541E10F6-9CDA-4E33-8762-6272C0AFE941 Q26801775-978F311D-75DB-4F3B-8E8D-9E86B299E910 Q28069234-81907846-63BA-49BC-B13E-A7DCBB92C464 Q28073428-0424806F-7C70-4755-BA52-5AE24A9A088C Q28087002-697CB4E0-4DDD-47DB-A6C6-CCF09A045273 Q30245404-5A077F11-90D9-4D29-83C8-5D117216D059 Q30276294-38331031-1B1D-415A-962C-CD943180F587 Q33165334-DEE5C85C-A7E4-4116-99B6-EF8B9930AF40 Q33625524-BAE46C92-43D2-4D04-A30F-91C8C5C1896B Q35245427-7E392515-D5D1-44FB-9BF8-881EC99169DB Q36249399-40A82A92-3087-4D35-91F6-7FE6A27362AF Q36477873-42FDC312-1DD5-49A6-A7F6-24E70C8CC041 Q36541500-C0874F88-A55E-433C-8D71-71AFBA76BFD1 Q36670175-7537513A-AB3D-4FD9-AF06-1794D9827363 Q36794947-196B05F1-F41B-4CFE-AC9D-C46B26377835 Q36956707-FD636AEA-0461-46E5-AA69-BD01CC2EF2DE Q37017457-19405BFA-F7A0-4B03-9770-1E3C13C81751 Q37176025-B109E8D4-1043-4237-B965-BA779C0A4EC5 Q37543559-51538CE9-86BE-43EE-83CF-403A4B399710 Q37556074-4435429A-C3A8-4641-96D0-E66B6F5C4E14 Q37683579-A59F7E32-4DC0-4B64-939E-077DC870793D Q37718443-FD5B61FA-28C8-4E06-B020-F2DF8D2EB1A4 Q38255985-62473E81-CE05-481E-88D0-541D6A54837E Q38353696-FC0FEDB3-01D4-4C28-966F-42CB3E7460F1 Q38432173-25CA94E1-A480-482F-B092-07B02ED44C16 Q38541252-31A8D91E-CCF7-405A-90E2-4F153FA6C6E8 Q38574702-2BDE19B8-F7FB-44A0-B7F8-6833C16C303C Q38602609-D4FD7C03-E6E5-459E-BF1D-4C36D7F6C4B4 Q38661618-708DBF40-02C8-41BC-BA9F-176AD4A88662 Q38732508-E87B4B1C-5DAE-44BC-B6CA-52636BE28807 Q38742921-42F018CF-D05F-487E-B69F-B1215848A555 Q38802904-E60F901C-67B6-4EFF-9407-E77059217819 Q38829878-BC271CBA-956C-4B06-8E2A-6450F908D03E Q38830086-CCEDE783-E8FA-4491-B821-DAB0E752EAEC Q38851511-7034A325-9AF8-49C3-98A1-510F40A4ED14 Q38911750-1158B59F-0D75-4D14-B12F-F6E549C7A025 Q38919543-AE84364D-3AE0-44C1-AFF4-7D1F5A35A6BA Q38920755-833C0374-737E-41DA-8E5B-4A3035A06416

P2860

HRS expert consensus statement on the diagnosis and management of arrhythmias associated with cardiac sarcoidosis.

http://www.wikidata.org/entity/Q34419644

description

2014 nî lūn-bûn

@nan

2014 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

HRS expert consensus statement ...... ated with cardiac sarcoidosis.

@ast

HRS expert consensus statement ...... ated with cardiac sarcoidosis.

@en

HRS expert consensus statement ...... ated with cardiac sarcoidosis.

@nl

type

label

HRS expert consensus statement ...... ated with cardiac sarcoidosis.

@ast

HRS expert consensus statement ...... ated with cardiac sarcoidosis.

@en

HRS expert consensus statement ...... ated with cardiac sarcoidosis.

@nl

prefLabel

HRS expert consensus statement ...... ated with cardiac sarcoidosis.

@ast

HRS expert consensus statement ...... ated with cardiac sarcoidosis.

@en

HRS expert consensus statement ...... ated with cardiac sarcoidosis.

@nl

P1433

Q34419644-105B598F-1AD1-45EC-BF02-43C48EF48C19

P1476

Q34419644-89E3649C-7A0F-4D18-B9F8-D93804865386

P2093

Q34419644-2E2A9312-1E9A-4C94-B1CC-B395B50AE897

Q34419644-311E2E96-7138-45D7-8DCB-9E408617E07D

Q34419644-38D501FC-8247-46D3-BE74-EEFFCD7A052E

Q34419644-5A85B45F-B9C5-49D0-B416-3726A141B4F1

Q34419644-78268030-6AAB-46C4-81B6-2E873BB20FB0

Q34419644-7F101C87-0D9D-43E9-AEA7-BBDAF44DE62A

Q34419644-89B3AE5F-7267-482D-9155-5F78B752C5F9

Q34419644-92B5C14E-5AFF-46E9-8B63-9B5CEFE422F9

Q34419644-A6E640F3-3E1A-4559-B02F-8A5703BDDD32

Q34419644-DDB0B555-8A76-4206-8ADB-FBB24F2B4B73

P304

Q34419644-BBB3EBB0-D4EA-4C4E-8D86-CEA451ED1870

P31

Q34419644-DA7FBC30-53BB-419F-8B2C-E231C3DA881D

P356

Q34419644-48BF8E57-4645-4A43-BBD6-C053FD278D68

P433

Q34419644-4CEF835C-3AA0-4A89-B385-A5136E50C33A

P478

Q34419644-3732824C-7B4D-43E5-B3FF-5E7838BAAB6E

P577

Q34419644-7CADF8FD-635F-44E4-83BC-11300A1DD1F7

P5875

Q34419644-EC367BE7-D626-41D9-BFFC-9946FF977B98

P698

Q34419644-767E05AE-B5FD-4863-BC3E-0D70C1544EF0

P356

J.HRTHM.2014.03.043

P1433

P1476

HRS expert consensus statement ...... ated with cardiac sarcoidosis.

@en

P2093

Amit R Patel

http://www.w3.org/2001/XMLSchema#string

Claire S Duvernoy

http://www.w3.org/2001/XMLSchema#string

Daniel A Culver

http://www.w3.org/2001/XMLSchema#string

Davendra Mehta

http://www.w3.org/2001/XMLSchema#string

David H Birnie

http://www.w3.org/2001/XMLSchema#string

Frank Bogun

http://www.w3.org/2001/XMLSchema#string

Jens Cosedis Nielsen

http://www.w3.org/2001/XMLSchema#string

Jordana Kron

http://www.w3.org/2001/XMLSchema#string

Joshua M Cooper

http://www.w3.org/2001/XMLSchema#string

Kyoko Soejima

http://www.w3.org/2001/XMLSchema#string

P304

1305-1323

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.HRTHM.2014.03.043

http://www.w3.org/2001/XMLSchema#string

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

11

http://www.w3.org/2001/XMLSchema#string

P577

2014-05-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

262268450

http://www.w3.org/2001/XMLSchema#string

P698

24819193

http://www.w3.org/2001/XMLSchema#string